Stevia Corp. Secures $20 Million in Financing - Enters Into Equity Purchase Agreement With Southridge Partners II

SMTP.com Announces Expansion across Western Europe - Cloud-based Email Delivery and Messaging Leader Maintains Focus on Multinational Business Development

EMULEX ANNOUNCES SECOND FISCAL QUARTER 2012 RESULTS - Net Revenues Grow 13% and Non-GAAP Net Income Increases 69% Year-Over-Year

Hondo Minerals Exploring New Market Opportunities Using Proprietary Extraction Technology

ATTUNITY REPORTS FOURTH QUARTER AND FULL YEAR 2011 FINANCIAL RESULTS - A 83% INCREASE IN NON-GAAP NET INCOME FOR 2011 TOTAL REVENUES INCREASED 51% TO $15.2 MILLION IN 2011

Liberty Silver Initiates Drilling Program on its Trinity Project

Rackwise, Inc. Announces New Version of DCiM Software - Intel and Rackwise to jointly market worldwide rollout

North Springs Resources Completes Planning for Phase One Exploration at Formerly Producing Imperial Gold and Silver Property in Nevada

Amarantus BioSciences Licenses Parkinson’s Disease Diagnostic Biomarker

QualityStocks would like to highlight Amarantus BioSciences, Inc. (OTCBB: AMBS), a California-based development-stage biotechnology company founded in January 2008.

La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist - Clinical-Stage Compound Inhibits Novel Molecular Target Implicated in Cancer and Chronic Organ Failure

INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA

First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial - Important Step in Process to Secure Regulatory Approval for RenalGuard in the United States

Duplicate -- Do Not Release INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA

Onyx (ONYX) Shifts Focus to Peru, Honduras for New “Plug-N-Play” Solar Panels to Achieve Economic Potential

National Technical Systems (NTSC) Inks Agreement with RF Exposure Lab to Expand Wireless Solutions and Services

Provectus Pharmaceuticals (PVCT) Receives FDA Guidance, Moves toward Approval of Phase 3 Trial for PV-10 for Metastatic Melanoma

STWA (ZERO) CEO to Address Key Decision Makers in China’s Oil Industry to Promote AOT™ Technology

Kyte will be joined by Ruilin Zhao, founder and CEO of Beijing Heng He Xing Ye Technology Development Co., Ltd., with which STWA recently signed a letter of intent for the licensing, sales and distribution of AOT™ into the Chinese market.

InVivo Therapeutics (NVIV), Geisinger Health System to Conduct Clinical Studies for Treatment of Chronic Pain Associated with Peripheral Nerve Injury

UFood Restaurant Group (UFFC) Grants Franchise Agreement for 10 UFood Grill Units in British Columbia

One E-Commerce Corp. (ONCE) Subsidiary Signs Alliance and Service Agreement with Progenitor Cell Therapy